Ghorbani Zahra, Shakiba Mohammad, Rezavand Negin, Rahimi Ziba, Vaisi-Raygani Asad, Rahimi Zohreh, Shakiba Ebrahim
Department of Clinical Biochemistry, Medical School, Kermanshah University of Medical Sciences , Kermanshah, Iran.
Department of Obstetrics and Gynecology, Kermanshah University of Medical Sciences , Kermanshah, Iran.
Hypertens Pregnancy. 2021 Feb;40(1):1-8. doi: 10.1080/10641955.2020.1849274. Epub 2020 Dec 11.
: To find whether the gene variants and haplotypes of cytochrome (CYP) 27B1 (1α-hydroxylase), group-specific component (GC) that is a vitamin D binding protein, vitamin D receptor (VDR), peroxisome proliferator-activated receptor γ (PPARγ) and retinoid-X receptor (RXR) affect the risk of preeclampsia. : In a case-control study 100 women with preeclampsia and 100 healthy pregnant women were investigated for gene variants and haplotypes of vitamin D biosynthesis, transport, and function using the polymerase chain reaction-restriction fragment length polymorphism method. : The frequency of gene variants of PPARγ Pro12Ala and RXR -α (A/G, rs749759) were not significantly different comparing patients and controls. The TT genotype of CYP 27B1 (G > T) was associated with 2.2-fold (95% CI 1.04-4.7, p = 0.039) increased risk of early-onset preeclampsia. Also, the TT genotype of GC rs7041 (T > G) increased the risk of preeclampsia [OR = 2.13 (95% CI 1.09-4.17, p = 0.027)]. The VDR ApaI GT genotype elevated susceptibility to preeclampsia (OR = 2.55, p = 0.04). Further, the presence of VDR ApaI GT+TT genotype was associated with higher levels of body mass index, and systolic blood pressure, and lower level of 25 (OH)-D3. In the presence of haplotype CYP T, VDR T, and RXR A (TTA) compared to haplotype GTG the risk of preeclampsia was 6.71-fold (p = 0.044). : The present study indicated an association between the CYP 27B1, GC, and VDR ApaI variants with the risk of preeclampsia. Also, the variants of the latter polymorphism influenced BMI, blood pressure, and vitamin D levels.
探究细胞色素(CYP)27B1(1α-羟化酶)、作为维生素D结合蛋白的组特异性成分(GC)、维生素D受体(VDR)、过氧化物酶体增殖物激活受体γ(PPARγ)和视黄酸X受体(RXR)的基因变异和单倍型是否会影响子痫前期的风险。
在一项病例对照研究中,采用聚合酶链反应-限制性片段长度多态性方法,对100例子痫前期患者和100例健康孕妇的维生素D生物合成、转运及功能的基因变异和单倍型进行了研究。
PPARγ Pro12Ala和RXR-α(A/G,rs749759)的基因变异频率在患者和对照组之间无显著差异。CYP 27B1(G>T)的TT基因型与早发型子痫前期风险增加2.2倍(95%可信区间1.04-4.7,p=0.039)相关。此外,GC rs7041(T>G)的TT基因型增加了子痫前期风险[比值比(OR)=2.13(95%可信区间1.09-4.17,p=0.027)]。VDR ApaI GT基因型增加了子痫前期易感性(OR=2.55,p=0.04)。此外VDR ApaI GT+TT基因型的存在与较高的体重指数、收缩压水平以及较低的25(OH)-D3水平相关。与单倍型GTG相比,单倍型CYP T、VDR T和RXR A(TTA)存在时子痫前期风险为6.71倍(p=0.044)。
本研究表明CYP 27B1、GC和VDR ApaI变异与子痫前期风险之间存在关联。此外,后一种多态性的变异影响体重指数、血压和维生素D水平。